CSL Limited ( CMXHF) - Stock Earnings
CMXHF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 18, 2026, midnight | — / — | — | — / — | — |
CMXHF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | 1.7 billion USD | 7.3 billion USD |
| 2023Q2 | 595.3 million USD | 5.9 billion USD |
| 2023Q4 | 2.0 billion USD | 8.4 billion USD |
CMXHF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 2.4 billion USD | 10.3 billion USD |
| 2022 | 2.3 billion USD | 10.5 billion USD |
| 2023 | 2.2 billion USD | 13.2 billion USD |
CMXHF
Price: $83.86
Dividend Yield: 3.51%
Forward Dividend Yield: 6.20%
Payout Ratio: 43.59%
Dividend Per Share: 5.20 USD
Earnings Per Share: 6.17 USD
P/E Ratio: 17.20
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Market Capitalization: 39.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 33
DGR3: 30.00%
DGR5: 29.51%
DGR10: 21.74%
DGR20: 20.17%